todralazine has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, M; Murata, K; Nakano, T; Sugimoto, K | 1 |
| Drózdz, M; Kucharz, EJ; Olczyk, K | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
3 other study(ies) available for todralazine and Disease Models, Animal
| Article | Year |
|---|---|
A novel mechanism for drug-induced liver failure: inhibition of histone acetylation by hydralazine derivatives.
Topics: Acetylation; Acetyltransferases; Animals; Arylamine N-Acetyltransferase; Disease Models, Animal; fas Receptor; Female; Histones; Humans; Hydralazine; Liver; Liver Failure; Liver Regeneration; Mice; Todralazine | 2007 |
Influence of long-term treatment with hydrazinophthalazines on the activity of lysosomal exoglycosidases in rat tissues.
Topics: Animals; Antibodies, Anti-Idiotypic; Disease Models, Animal; Glycoside Hydrolases; Hydralazine; Hydrazines; Lupus Erythematosus, Systemic; Lysosomes; Male; Organ Specificity; Rats; Rats, Inbred Strains; Reference Values; Todralazine | 1988 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |